HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-Vascular Endothelial Growth Factor Antibody Suppresses ERK and NF-κB Activation in Ischemia-Reperfusion Lung Injury.

Abstract
Ischemia-reperfusion (IR)-induced acute lung injury (ALI) is implicated in several clinical conditions like lung transplantation, acute pulmonary embolism after thrombolytic therapy, re-expansion of collapsed lung from pneumothorax or pleural effusion, cardiopulmonary bypass and etc. Because mortality remains high despite advanced medical care, prevention and treatment are important clinical issues for IR-induced ALI. Vascular endothelial growth factor (VEGF) has a controversial role in ALI. We therefore conducted this study to determine the effects of anti-VEGF antibody in IR-induced ALI. In the current study, the IR-induced ALI was conducted in a rat model of isolated-perfused lung in situ in the chest. The animals were divided into the control, control + preconditioning anti-VEGF antibody (bevacizumab, 5mg/kg), IR, IR + preconditioning anti-VEGF antibody (1mg/kg), IR+ preconditioning anti-VEGF antibody (5mg/kg) and IR+ post-IR anti-VEGF antibody (5mg/kg) group. There were eight adult male Sprague-Dawley rats in each group. The IR caused significant pulmonary micro-vascular hyper-permeability, pulmonary edema, neutrophilic infiltration in lung tissues, increased tumor necrosis factor-α, and total protein concentrations in bronchoalveolar lavage fluid. VEGF and extracellular signal-regulated kinase (ERK) were increased in IR-induced ALI. Administration of preconditioning anti-VEGF antibody significantly suppressed the VEGF and ERK expressions and attenuated the IR-induced lung injury. This study demonstrates the important role of VEGF in early IR-induced ALI. The beneficial effects of preconditioning anti-VEGF antibody in IR-induced ALI include the attenuation of lung injury, pro-inflammatory cytokines, and neutrophilic infiltration into the lung tissues.
AuthorsChou-Chin Lan, Chung-Kan Peng, Shih-En Tang, Shu-Yu Wu, Kun-Lun Huang, Chin-Pyng Wu
JournalPloS one (PLoS One) Vol. 11 Issue 8 Pg. e0159922 ( 2016) ISSN: 1932-6203 [Electronic] United States
PMID27513332 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Cytokines
  • NF-kappa B
  • Vascular Endothelial Growth Factor A
  • Extracellular Signal-Regulated MAP Kinases
Topics
  • Acute Lung Injury (etiology, metabolism, pathology, prevention & control)
  • Animals
  • Antibodies, Monoclonal (pharmacology)
  • Capillary Permeability (drug effects)
  • Cytokines (metabolism)
  • Extracellular Signal-Regulated MAP Kinases (antagonists & inhibitors, metabolism)
  • Gene Expression Regulation (drug effects)
  • Inflammation (etiology, metabolism, pathology, prevention & control)
  • Male
  • NF-kappa B (antagonists & inhibitors, metabolism)
  • Pulmonary Edema (etiology, metabolism, pathology, prevention & control)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (complications)
  • Signal Transduction (drug effects)
  • Vascular Endothelial Growth Factor A (antagonists & inhibitors, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: